-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Kestra Medical Technologies, Ltd. (KMTS) Reports Q3 Loss of $0.50, provides guidance
-
Piper Sandler on Kestra Medical Technologies (KMTS): 'Buy Any Weakness Tomorrow'
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Kestra Medical Technologies, Ltd. (KMTS) Reports Q2 Loss of $2.21
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Stifel Reiterates Buy Rating on Kestra Medical Technologies (KMTS)
-
Piper Sandler on Kestra Medical Technologies (KMTS): 'A Unique Duopoly Name to Own Here'
-
Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
-
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
-
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
-
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
-
Kestra Medical Technologies initiates trading at $22.95, after $17 IPO
-
Kestra Medical Technologies (KMTS) Prized Upsized 11.88M Share IPO at $17/sh
-
Kestra Medical Technologies (KMTS) shares indicate $27.20 after pricing IPO at $17

